o2h Ventures is thrilled to announce that it has been recognised as Runner-Up in the Best EIS Investment Manager — Specialist category at the 2025 Growth Investor Awards, hosted by Intelligent Partnership.
The award celebrates investment managers with a clear specialist focus and a track record of driving meaningful impact through the Enterprise Investment Scheme (EIS). It highlights those who use investment as a genuine force for good — creating both commercial success and positive societal outcomes.
As a biotech-specialist tax-efficient fund manager, o2h Ventures continues to champion early-stage life science and health-tech innovation across the UK. We have now invested in 35+ portfolio companies, working on groundbreaking solutions across oncology, depression, dermatology, fibrosis, infectious disease, and anti-ageing — all focused on making a tangible difference to patients’ lives.
This year’s recognition follows o2h Ventures’ win in the same category in 2024, reaffirming our continued leadership and dedication to nurturing the UK’s biotech ecosystem.
Learn more about our EIS and SEIS funds at o2hventures.com/funds